M A Vogelbaum

Summary

Affiliation: Cleveland Clinic Foundation
Country: USA

Publications

  1. doi request reprint Application of novel response/progression measures for surgically delivered therapies for gliomas: Response Assessment in Neuro-Oncology (RANO) Working Group
    Michael A Vogelbaum
    Brain Tumor and Neuro Oncology Center, Department of Neurosurgery, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Neurosurgery 70:234-43; discussion 243-4. 2012
  2. pmc Phase II trial of preirradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: RTOG BR0131
    Michael A Vogelbaum
    Cleveland Clinic, Brain Tumor and NeuroOncology Center, Cleveland, OH 44195, USA
    Neuro Oncol 11:167-75. 2009
  3. doi request reprint Opportunities for clinical research in meningioma
    Michael A Vogelbaum
    Brain Tumor and NeuroOncology Center, Cleveland Clinic, Cleveland, OH 44195, USA
    J Neurooncol 99:417-22. 2010
  4. doi request reprint Novel drug delivery strategies in neuro-oncology
    Dani S Bidros
    Department of Neurological Surgery, Brain Tumor and NeuroOncology Center, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, USA
    Neurotherapeutics 6:539-46. 2009
  5. ncbi request reprint RPA classification has prognostic significance for surgically resected single brain metastasis
    Rahul D Tendulkar
    Department of Radiation Oncology, Brain Tumor Institute, Cleveland Clinic, Cleveland, OH 44195, USA
    Int J Radiat Oncol Biol Phys 66:810-7. 2006
  6. doi request reprint Long-term experience with World Health Organization grade III (malignant) meningiomas at a single institution
    Lewis A Rosenberg
    Department of Radiation Oncology, Cleveland Clinic Foundation, OH 44195, USA
    Int J Radiat Oncol Biol Phys 74:427-32. 2009
  7. doi request reprint Future of convection-enhanced delivery in the treatment of brain tumors
    Dani S Bidros
    Brain Tumor and NeuroOncology Center, Department of Neurological Surgery, Neurological Institute, Cleveland Clinic, OH 44195, USA
    Future Oncol 6:117-25. 2010
  8. ncbi request reprint Five-year survivors of brain metastases: a single-institution report of 32 patients
    Samuel T Chao
    Department of Radiation Oncology, Brain Tumor Institute, Taussig Cancer Center, The Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Int J Radiat Oncol Biol Phys 66:801-9. 2006
  9. ncbi request reprint Brain metastases from esophageal cancer: a phenomenon of adjuvant therapy?
    Thomas W Rice
    The Center for Swallowing and Esophageal Disorders, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Ann Thorac Surg 82:2042-9, 2049.e1-2. 2006
  10. ncbi request reprint Convection enhanced delivery for treating brain tumors and selected neurological disorders: symposium review
    Michael A Vogelbaum
    Brain Tumor Institute, Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, OH 44195, USA
    J Neurooncol 83:97-109. 2007

Collaborators

Detail Information

Publications44

  1. doi request reprint Application of novel response/progression measures for surgically delivered therapies for gliomas: Response Assessment in Neuro-Oncology (RANO) Working Group
    Michael A Vogelbaum
    Brain Tumor and Neuro Oncology Center, Department of Neurosurgery, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Neurosurgery 70:234-43; discussion 243-4. 2012
    ..The RANO group identified knowledge gaps relating to the definitions of tumor response and progression after the use of surgical or surgically based treatments...
  2. pmc Phase II trial of preirradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: RTOG BR0131
    Michael A Vogelbaum
    Cleveland Clinic, Brain Tumor and NeuroOncology Center, Cleveland, OH 44195, USA
    Neuro Oncol 11:167-75. 2009
    ..Future studies will need to prospectively stratify patients according to the presence of deletions of chromosomes 1p and 19q...
  3. doi request reprint Opportunities for clinical research in meningioma
    Michael A Vogelbaum
    Brain Tumor and NeuroOncology Center, Cleveland Clinic, Cleveland, OH 44195, USA
    J Neurooncol 99:417-22. 2010
    ..Finally, we discuss ongoing efforts to develop new trials to more definitively address important therapeutic questions...
  4. doi request reprint Novel drug delivery strategies in neuro-oncology
    Dani S Bidros
    Department of Neurological Surgery, Brain Tumor and NeuroOncology Center, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, USA
    Neurotherapeutics 6:539-46. 2009
    ..In this review, we describe the clinically available methods used to circumvent the blood brain barrier and summarize the results to date of ongoing and completed clinical trials...
  5. ncbi request reprint RPA classification has prognostic significance for surgically resected single brain metastasis
    Rahul D Tendulkar
    Department of Radiation Oncology, Brain Tumor Institute, Cleveland Clinic, Cleveland, OH 44195, USA
    Int J Radiat Oncol Biol Phys 66:810-7. 2006
    ..To retrospectively evaluate prognostic factors that correlate with overall survival among patients with a surgically resected single brain metastasis...
  6. doi request reprint Long-term experience with World Health Organization grade III (malignant) meningiomas at a single institution
    Lewis A Rosenberg
    Department of Radiation Oncology, Cleveland Clinic Foundation, OH 44195, USA
    Int J Radiat Oncol Biol Phys 74:427-32. 2009
    ..To evaluate the outcomes for patients with Grade III meningiomas as defined by the 2007 World Health Organization standards...
  7. doi request reprint Future of convection-enhanced delivery in the treatment of brain tumors
    Dani S Bidros
    Brain Tumor and NeuroOncology Center, Department of Neurological Surgery, Neurological Institute, Cleveland Clinic, OH 44195, USA
    Future Oncol 6:117-25. 2010
    ..In this review, we summarize the recent past of the clinical trials utilizing CED and discuss emerging technologies that will shape future CED trials...
  8. ncbi request reprint Five-year survivors of brain metastases: a single-institution report of 32 patients
    Samuel T Chao
    Department of Radiation Oncology, Brain Tumor Institute, Taussig Cancer Center, The Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Int J Radiat Oncol Biol Phys 66:801-9. 2006
    ..To report on 32 patients who survived > or = 5 years from brain metastases treated at a single institution...
  9. ncbi request reprint Brain metastases from esophageal cancer: a phenomenon of adjuvant therapy?
    Thomas W Rice
    The Center for Swallowing and Esophageal Disorders, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Ann Thorac Surg 82:2042-9, 2049.e1-2. 2006
    ..Therefore, we determined (1) incidence and prevalence of, risk factors for, and survival after development of brain metastases following esophagectomy for esophageal cancer, and (2) their association with adjuvant therapy...
  10. ncbi request reprint Convection enhanced delivery for treating brain tumors and selected neurological disorders: symposium review
    Michael A Vogelbaum
    Brain Tumor Institute, Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, OH 44195, USA
    J Neurooncol 83:97-109. 2007
    ..Each speaker's presentation has been abstracted along with relevant references...
  11. ncbi request reprint Local control of brain metastases by stereotactic radiosurgery in relation to dose to the tumor margin
    Michael A Vogelbaum
    Brain Tumor Institute and Departments of Biostatistics, Neurosurgery, and Radiation Oncology, Cleveland Clinic, Cleveland, Ohio 44195, USA
    J Neurosurg 104:907-12. 2006
    ..The goal in this retrospective study was to determine whether differences in doses to the margins of brain metastases affect the ability of SRS to achieve local control...
  12. ncbi request reprint Convection-enhanced delivery of cintredekin besudotox (interleukin-13-PE38QQR) followed by radiation therapy with and without temozolomide in newly diagnosed malignant gliomas: phase 1 study of final safety results
    Michael A Vogelbaum
    Brain Tumor and Neuro Oncology Center, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Neurosurgery 61:1031-7; discussion 1037-8. 2007
    ....
  13. doi request reprint Stereotactic radiosurgical treatment of parenchymal brain metastases from prostate adenocarcinoma
    Se Hyuk Kim
    The Brain Tumor and Neuro Oncology Center, Cleveland Clinic, Cleveland, OH 44195, USA
    Surg Neurol 69:641-6; discussion 646. 2008
    ..Prostate cancer metastatic to the brain is uncommon and has been associated historically with a poor prognosis. It has been suggested that SRS may be an effective treatment...
  14. doi request reprint Stereotactic radiosurgery as single-modality treatment of incidentally identified renal cell carcinoma brain metastases
    Nicholas F Marko
    Department of Neurosurgery, The Cleveland Clinic, Cleveland, OH 44195, USA
    World Neurosurg 73:186-93; discussion e29. 2010
    ....
  15. doi request reprint Gender, race, and survival: a study in non-small-cell lung cancer brain metastases patients utilizing the radiation therapy oncology group recursive partitioning analysis classification
    Gregory M M Videtic
    Department of Radiation Oncology, Taussig Cancer Institute, The Cleveland Clinic, Cleveland, OH 44195, USA
    Int J Radiat Oncol Biol Phys 75:1141-7. 2009
    ....
  16. ncbi request reprint Management of brain metastases
    John H Suh
    Brain Tumor and Neuro Oncology Center, Department of Radiation Oncology, T28, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Curr Neurol Neurosci Rep 9:223-30. 2009
    ..This review of the management of brain metastases focuses on whole brain radiation therapy, surgery, stereotactic radiosurgery, radiation sensitizers, and clinical trials...
  17. doi request reprint Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme
    David M Peereboom
    Brain Tumor and Neuro Oncology Center, Neurological Institute, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH 44195, USA
    J Neurooncol 98:93-9. 2010
    ..Erlotinib co administered with RT and temozolomide was not efficacious and had an unacceptable toxicity...
  18. doi request reprint Salvage stereotactic radiosurgery effectively treats recurrences from whole-brain radiation therapy
    Samuel T Chao
    Department of Radiation Oncology, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Cancer 113:2198-204. 2008
    ....
  19. ncbi request reprint Convection enhanced delivery for the treatment of malignant gliomas: symposium review
    Michael A Vogelbaum
    Brain Tumor Institute, Department of Neurosurgery, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    J Neurooncol 73:57-69. 2005
    ..Each speaker's talk has been abstracted and a list of relevant references has been compiled...
  20. ncbi request reprint Resectable brain metastases
    Michael A Vogelbaum
    Brain Tumor Institute ND40, Cleveland Clinic Foundation, Cleveland, OH, USA
    J Clin Oncol 24:1289-94. 2006
    ..As a result, overall survival is much more dependent on the status of the patient's systemic disease...
  21. ncbi request reprint Update of stereotactic radiosurgery for brain tumors
    John H Suh
    Department of Radiation Oncology, Brain Tumor Institute, Cleveland Clinic Taussig Cancer Center, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Curr Opin Neurol 17:681-6. 2004
    ..This paper will review the recent publications of stereotactic radiosurgery for brain tumors...
  22. doi request reprint Stereotactic radiosurgery for single brainstem metastases: the cleveland clinic experience
    Shlomo A Koyfman
    Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, OH, USA
    Int J Radiat Oncol Biol Phys 78:409-14. 2010
    ..To assess the imaging and clinical outcomes of patients with single brainstem metastases treated with stereotactic radiosurgery (SRS)...
  23. ncbi request reprint Cyclooxygenase-2 in oligodendroglial neoplasms
    Elias A Castilla
    Department of Anatomic Pathology, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Cancer 98:1465-72. 2003
    ..Although increased expression of cyclooxygenase-2 (COX-2) has been described in association with a variety of neoplasms, including tumors of astrocytic derivation, limited data are available on COX-2 expression in oligodendrogliomas...
  24. ncbi request reprint Epidermal growth factor receptor amplification does not have prognostic significance in patients with glioblastoma multiforme
    Aimee L Quan
    Department of Radiation Oncology, Brain Tumor Institute, The Cleveland Clinic Taussig Cancer Center, The Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Int J Radiat Oncol Biol Phys 63:695-703. 2005
    ..The purpose of this study is to determine the prognostic significance of EGFR amplification in patients with GBM treated at the Cleveland Clinic Foundation...
  25. ncbi request reprint Posterior fossa metastases: aggressive treatment improves survival
    Andrew A Kanner
    Department of Neurosurgery, Brain Tumor Institute, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Stereotact Funct Neurosurg 81:18-23. 2003
    ..Brain metastases are a leading cause of mortality and morbidity in patients with malignancies. Infratentorial location has been considered a negative prognostic factor...
  26. ncbi request reprint Current concepts and newer developments in the treatment of malignant gliomas
    S B Omay
    Cleveland Clinic Brain Tumor and Neuro Oncology Center, 9500 Euclid Avenue, Cleveland, OH 441 95, USA
    Indian J Cancer 46:88-95. 2009
    ..Further progress towards a cure for malignant gliomas will require a greater understanding of the underlying mechanisms driving the growth, and resistance to therapy, of these challenging tumors...
  27. ncbi request reprint Posterior fossa metastases: risk of leptomeningeal disease when treated with stereotactic radiosurgery compared to surgery
    Vitaly E Siomin
    Department of Neurosurgery, Brain Tumor Institute, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    J Neurooncol 67:115-21. 2004
    ..Our objective was to compare the incidence of LMD in patients with posterior fossa metastases (PFM) following stereotactic radiosurgery (SRS) versus surgical resection...
  28. doi request reprint Modern treatment of cerebral metastases: Integrated Medical Learning(SM) at CNS 2007
    Michael A Vogelbaum
    Brain Tumor and Neuro Oncology Center, The Cleveland Clinic Foundation, Cleveland, OH, USA
    J Neurooncol 93:89-105. 2009
    ....
  29. ncbi request reprint Inhibition of constitutively active Stat3 suppresses proliferation and induces apoptosis in glioblastoma multiforme cells
    Shaik Ohidar Rahaman
    Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, Ohio, OH 44195, USA
    Oncogene 21:8404-13. 2002
    ..Therefore, targeting Stat3 signaling may provide a potential therapeutic intervention for GBM...
  30. ncbi request reprint S100beta as a predictor of brain metastases: brain versus cerebrovascular damage
    Michael A Vogelbaum
    Brain Tumor Institute, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Cancer 104:817-24. 2005
    ....
  31. ncbi request reprint The impact of genotype on outcome in oligodendroglioma: validation of the loss of chromosome arm 1p as an important factor in clinical decision making
    Andrew A Kanner
    The Brain Tumor Institute, The Cleveland Clinic Taussig Cancer Center, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    J Neurosurg 104:542-50. 2006
    ..Anaplastic oligodendrogliomas with allelic loss of 1p have been associated with chemosensitivity and a longer patient survival period...
  32. doi request reprint Stereotactic radiosurgical treatment of brain metastases in older patients
    Se Hyuk Kim
    The Brain Tumor and Neuro Oncology Center, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Cancer 113:834-40. 2008
    ..This study was designed to evaluate the therapeutic effect of stereotactic radiosurgery (SRS) in patients aged > or =75 years who presented with brain metastasis...
  33. pmc PTPmu suppresses glioma cell migration and dispersal
    Adam M Burgoyne
    Department of Molecular Biology and Microbiology, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA
    Neuro Oncol 11:767-78. 2009
    ..Together, these data suggest that loss of PTPmu in human GBMs contributes to tumor cell migration and dispersal, implicating loss of PTPmu in glioma progression...
  34. ncbi request reprint Mapping prosody: correlation of functional magnetic resonance imaging with intraoperative electrocorticography recordings in a patient with a right-sided temporooccipital glioma. Case illustration
    Narendra Nathoo
    Brain Tumor Institute, The Taussig Cancer Center, Cleveland, Ohio 44195, USA
    J Neurosurg 103:930. 2005
  35. ncbi request reprint Cyclooxygenase-2 (COX-2) expression by immunohistochemistry in glioblastoma multiforme
    Richard A Prayson
    Brain Tumor Center and the Department of Pathology, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Ann Diagn Pathol 6:148-53. 2002
    ..These findings are significant in that therapeutic agents, which inhibit COX-2, are currently available and may play a role in the management of glioblastoma multiforme...
  36. ncbi request reprint Use of the Radiation Therapy Oncology Group recursive partitioning analysis classification system and predictors of survival in 19 women with brain metastases from ovarian carcinoma
    Philip G Chen
    Department of Radiation Oncology, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Cancer 104:2174-80. 2005
    ....
  37. pmc Histidine-rich glycoprotein modulates the anti-angiogenic effects of vasculostatin
    Philip A Klenotic
    Department of Cell Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA
    Am J Pathol 176:2039-50. 2010
    ..These data help define a novel angiogenic axis that could be exploited for the treatment of human cancers and other diseases where excess angiogenesis occurs...
  38. ncbi request reprint Aberrant constitutive activation of nuclear factor kappaB in glioblastoma multiforme drives invasive phenotype
    Baisakhi Raychaudhuri
    Brain Tumor Institute and Taussig Cancer Center, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    J Neurooncol 85:39-47. 2007
    ..Interruption of this aberrant NF-kappaB activity may help reduce the spread of this infiltrative tumor...
  39. ncbi request reprint Intracranial collision tumor mimicking an octreotide-SPECT positive and FDG-PET negative meningioma
    Ali Chahlavi
    Department of Neurosurgery, The Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    J Clin Neurosci 12:720-3. 2005
    ..We report an unusual case of a "collision tumor" consisting of a renal cell carcinoma metastasis to an intracranial meningioma...
  40. ncbi request reprint IL-13R(alpha)2, a decoy receptor for IL-13 acts as an inhibitor of IL-4-dependent signal transduction in glioblastoma cells
    Shaik Ohidar Rahaman
    Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Cancer Res 62:1103-9. 2002
    ..Thus, IL-13R(alpha)2 acts as an inhibitor of IL-4-dependent signal transduction pathways via a novel mechanism that is independent of ligand binding...
  41. pmc Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma
    Baisakhi Raychaudhuri
    Brain Tumor and Neuro Oncology Center, Neurological Institute, Cleveland, OH, USA
    Neuro Oncol 13:591-9. 2011
    ..Increased plasma levels of arginase and G-CSF may relate to MDSC suppressor function and MDSC expansion, respectively, in patients with glioma...
  42. ncbi request reprint Results of a survey of neurosurgical practice patterns regarding the prophylactic use of anti-epilepsy drugs in patients with brain tumors
    Vitaly Siomin
    Department of Neurosurgery, The Cleveland Clinic Brain Tumor Institute, 9500 Euclid Avenue, ND 40, Cleveland, OH 44195, USA
    J Neurooncol 74:211-5. 2005
    ..We surveyed neurosurgeons to evaluate practice patterns with regard to using AEDs in neurosurgical patients with brain tumors...
  43. ncbi request reprint Quantum dots are phagocytized by macrophages and colocalize with experimental gliomas
    Heather Jackson
    Brain Tumor Institute, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Neurosurgery 60:524-9; discussion 529-30. 2007
    ..This feature may allow optical nanoparticles, such as quantum dots, to colocalize with brain tumors and serve as an optical aid in the surgical resection or biopsy of brain tumors...
  44. ncbi request reprint In touch with robotics: neurosurgery for the future
    Narendra Nathoo
    Brain Tumor Institute and Department of Neurosurgery, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Neurosurgery 56:421-33; discussion 421-33. 2005
    ..This article reviews the role of robotic technology in the context of neurosurgery...